Improving the quality of life of persons with intellectual disabilities and their families

Opened

Programme Category

EU Competitive Programmes

Programme Name

Horizon Europe (2021-2027)

Programme Description

Horizon Europe is the European Union (EU) funding programme for the period 2021 – 2027, which targets the sectors of research and innovation. The programme’s budget is around € 95.5 billion, of which € 5.4 billion is from NextGenerationEU to stimulate recovery and strengthen the EU’s resilience in the future, and € 4.5 billion is additional aid.

Programme Details

Identifier Code

HORIZON-HLTH-2025-03-STAYHLTH-01-two-stage

Call

Improving the quality of life of persons with intellectual disabilities and their families

Summary

The scope of this topic is set by the definitions provided byThe international classification of diseases’ – World Health Organization (WHO) ICD11 under 6A00: Disorders of intellectual development’ and under ‘20: Developmental anomalies’  including disorders of intellectual development, such as ‘LD40: Complete trisomies of the autosomes’ and ‘LD90: Conditions with disorders of intellectual development as a relevant clinical feature’.

Moreover, the three types of autism with disorders of intellectual development (6A02.1, 6A02.3 and 6A02.5) under ‘6A02: Autism spectrum disorder’ are also within the scope of this topic.

The focus of this topic is human-centred on the persons with long-term intellectual disabilities and their formal and informal carers, including families.

The life expectancy of persons with intellectual disabilities has increased in the last 20 years, which makes it even more important to analyse the role of their families acting as informal carers (e.g. ageing parents).

Detailed Call Description

Innovative solutions are needed to provide novel medicines, diagnoses, treatments, protocols, technologies or digital solutions, etc. that can help in an early stage to prevent the worsening of the intellectual disability and/or related co-morbidities, reverse or reduce it, and to improve the autonomy of affected persons and relieve their carers.

Research actions under this topic should address several of the following areas:

  • To properly diagnose as early as possible the disease(s) causing the intellectual disability or conditions worsening them, especially in the case of children, and paying attention to sex and gender-related differences and diagnostic biases.
  • Deliver the necessary medical treatments, diagnoses, medicines, protocols, technologies, digital solutions, habilitation and/or rehabilitation services, etc. that can help preventing the worsening of the intellectual disability, reversing it or reducing its severity, while supporting the empowerment of the person with intellectual disabilities. Any health technology or medical intervention developed for human use must comply with the relevant regulatory requirements and be based on sound scientific evidence to ensure safety and efficacy.
  • Tackle comorbidities or other disabilities that persons with intellectual disabilities may suffer from, with awareness of sex and gender-related differences.
  • Provide evidence-based approaches for transitional care for young adults with intellectual disabilities, addressing also sex and gender-specific challenges and needs, the transition from paediatric to adult care being perceived as complex to navigate.
  • Promote the empowerment among persons with intellectual disabilities and their caregivers, and whenever possible remove barriers persons with intellectual disabilities face for their participation in society. If applicable, with the support of assistive technologies and digital solutions, ensure optimal autonomy of persons with intellectual disabilities, facilitate and improve the treatment of persons with intellectual disabilities, and help also the family members and close carers to better support persons with intellectual disabilities. Such technologies must adhere to the relevant standards and be grounded in scientific evidence.
  • Propose innovative solutions for high quality, accessible – including cognitively accessible – and affordable care services, to allow carers of persons with intellectual disabilities to better balance their work and family lives. The role of informal/unpaid carers, especially family members, is of key importance for persons with intellectual disabilities. For many persons with intellectual disabilities, the lack of care services and insufficient support for families and personal assistance undermines their quality of life and their rights and possibility to live as independently as possible.
  • Develop innovative integrated care strategies – strengthening patient-centred care – to improve the Quality of Life of persons with intellectual disabilities of any age, and their families, paying special attention to persons with intellectual disabilities with the highest vulnerability because of their high dependency on carers (formal and/or informal), multiple disabilities and need of adapted and special care (medical, social, educational and psychological dimensions).
  • Develop guidelines in order to provide adequate support and training for caregivers, formal and informal, especially for those providing care for persons with intellectual disabilities and/or living with them, and also addressing the issue of prevention of and protection from violence since persons with intellectual disabilities are both vulnerable to violence and abuse and can be violent towards care givers and family members.

Applicants are encouraged to include patients, their families and carers in the different stages of the research. Likewise, it is encouraged to involve stakeholders from within and outside the intellectual disabilities sector, in particular policymakers and public authorities, citizens and civil society organisations, end-users and service providers.

All projects funded under this topic are encouraged to participate in networking and joint activities, as appropriate. These networking and joint activities could, for example, involve the participation in joint workshops, the exchange of knowledge, the development and adoption of best practices, or joint communication activities. Therefore, proposals are expected to include a budget for the attendance to regular joint meetings and may consider covering the costs of any other potential joint activities without the prerequisite to detail concrete joint activities at this stage. The details of these joint activities will be defined during the grant agreement preparation phase.

Call Total Budget

€40.00 million

Financing percentage by EU or other bodies / Level of Subsidy or Loan

100%

Expected EU contribution per project: between €6.00 and €8.00 million.

Thematic Categories

  • Health
  • Information and Communication Technologies
  • Research, Technological Development and Innovation

Eligibility for Participation

  • Educational Institutions
  • Legal Entities
  • Natual person / Citizen / Individual
  • NGOs
  • Other Beneficiaries
  • Researchers/Research Centers/Institutions
  • Services Providers
  • Small and Medium Enterprises (SMEs)

Eligibility For Participation Notes

In recognition of the opening of the US National Institutes of Health’s programmes to European researchers, any legal entity established in the United States of America is eligible to receive Union funding.

If projects use satellite-based earth observation, positioning, navigation and/or related timing data and services, beneficiaries must make use of Copernicus and/or Galileo/EGNOS (other data and services may additionally be used).

A number of non-EU/non-Associated Countries that are not automatically eligible for funding have made specific provisions for making funding available for their participants in Horizon Europe projects.

Call Opening Date

22/05/2025

Call Closing Date

16/09/2025

National Contact Point(s)

Research and Innovation Foundation

29a Andrea Michalakopoulou, 1075 Nicosia,
P.B. 23422, 1683 Nicosia
Telephone: +357 22205000
Fax: +357 22205001
Email: support@research.org.cy
Websitehttps://www.research.org.cy/en/

Contact Person:
George Christou
Scientific Officer
Email: gchristou@research.org.cy